Mutual funds holding both BROOKS Laboratories and Zydus Wellness

Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 1 mutual funds hold active equity positions in both BROOKS Laboratories and Zydus Wellness. The scheme with the highest combined exposure is quant Business Cycle Fund (Quant MF), which holds a 1.97% stake in BROOKS Laboratories and a 3.62% stake in Zydus Wellness, amounting to a combined conviction weight of 5.59%.

When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.